Ligisan Pharmaceutical Private Limited
About Ligisan Pharmaceutical Private Limited
Data last updated:
Ligisan Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC313420. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajnikant Kamlakar Desai and Sumati Shrikant Hejib.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 1 Floor – Grd Upendra Nagar Senapati Bapat Marg Below Dadar Railway Foot Brdg, Mumbai, Maharashtra, India – 400028.
As per the financials filed for FY 2022, the company reported a revenue of ₹93,791, a decline of 73% compared to the previous year. For the same year it recorded a net loss of ₹1.51 Lakh (net margin -160.7%) and EBITDA of -₹1.41 Lakh (EBITDA margin -150.5%).
Company details
Contact details
Ligisan Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 Floor – Grd Upendra Nagar Senapati Bapat Marg Below Dadar Railway Foot Brdg, Mumbai, Maharashtra, India – 400028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ligisan Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ligisan Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ligisan Pharmaceutical Private Limited, buy the company report.
Financials of Ligisan Pharmaceutical Private Limited
FY 2022 filings availableLigisan Pharmaceutical Private Limited reported revenue of ₹93,791 (down 73% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹93,791 | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.41 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.51 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -150.5% | |||
| Net Profit Margin | -160.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ligisan Pharmaceutical Private Limited, buy the company report.
Board of directors of Ligisan Pharmaceutical Private Limited
Ligisan Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajnikant Kamlakar Desai Also directs: Greenergy Vehicles Private Limited | Director | 04 Sep 2018 | 8 Years 2 Months | Current |
| Sumati Shrikant Hejib | Director | 04 Sep 2018 | 8 Years 2 Months | Current |
Peer comparison
Ligisan Pharmaceutical Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Extoll Additives Private Limited | ₹95,000 (FY 2024) | -51.0% | Ahmedabad, Gujarat, India | |||
| Hazor Pharmaceuticals Private Limited | ₹93,979 (FY 2025) | -94.0% | Allahabad, Uttar Pradesh, India | |||
| Ligisan Pharmaceutical Private Limitedthis company | ₹93,791 (FY 2022) | -₹1.51 Lakh | -160.7% | -73.0% | Mumbai, Maharashtra, India | |
| S R S Marketing and Distribution Private Limited | ₹91,700 (FY 2020) | 21.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ligisan Pharmaceutical Private Limited, buy the company report.
Auditor
Ligisan Pharmaceutical Private Limited is audited by GODSE & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GODSE & ASSOCIATES | FY 2022 | 142480W |
Shareholding
The shareholding of Ligisan Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ligisan Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ligisan Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ligisan Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ligisan Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ligisan Pharmaceutical Private Limited, buy the company report.
Recent activity
Ligisan Pharmaceutical Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Roopali Sudhir Pundalik ceased to be Director on 28 Oct 2021.
Frequently asked questions
Ligisan Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 September 2018 (8+ years old) and is registered under CIN U74999MH2018PTC313420.
Ligisan Pharmaceutical has 2 current directors:
- Rajnikant Kamlakar Desai - Director
- Sumati Shrikant Hejib - Director
The latest financial statements of Ligisan Pharmaceutical on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
No. Ligisan Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ligisan Pharmaceutical is U74999MH2018PTC313420. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ligisan Pharmaceutical was incorporated on 04 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ligisan Pharmaceutical by revenue are Extoll Additives Private Limited, Hazor Pharmaceuticals Private Limited, S R S Marketing and Distribution Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Roopali Sudhir Pundalik ceased to be Director on 28 Oct 2021. Rajnikant Kamlakar Desai was appointed as Director on 04 Sep 2018. Sumati Shrikant Hejib was appointed as Director on 04 Sep 2018.
The registered office of Ligisan Pharmaceutical is at 1 Floor – Grd Upendra Nagar Senapati Bapat Marg Below Dadar Railway Foot Brdg, Mumbai, Maharashtra, India – 400028.
Ligisan Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Ligisan Pharmaceutical can be reached at its registered office: 1 Floor – Grd Upendra Nagar Senapati Bapat Marg Below Dadar Railway Foot Brdg, Mumbai, Maharashtra, India – 400028.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
